These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9529111)

  • 21. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.
    Kremer L; Dupré L; Riveau G; Capron A; Locht C
    Infect Immun; 1998 Dec; 66(12):5669-76. PubMed ID: 9826340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.
    Alonso S; Willery E; Renauld-Mongénie G; Locht C
    Infect Immun; 2005 Jul; 73(7):4295-301. PubMed ID: 15972522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of antibodies to Bordetella antigens in German adults.
    Saemann-Ischenko G; Tillmanns B; Kösters K; Riffelmann M; Wirsing von König CH
    Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):850-3. PubMed ID: 11837635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model.
    Watanabe M; Komatsu E; Abe K; Iyama S; Sato T; Nagai M
    Vaccine; 2002 Jan; 20(9-10):1429-34. PubMed ID: 11818163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
    Colombi D; Horton DS; Oliveira ML; Sakauchi MA; Ho PL
    FEMS Microbiol Lett; 2004 Nov; 240(1):41-7. PubMed ID: 15500977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
    Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
    Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.
    Annunziato PW; Rothstein EP; Bernstein HH; Blatter MM; Reisinger KS; Pichichero ME
    Arch Pediatr Adolesc Med; 1994 May; 148(5):503-7. PubMed ID: 8180641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.
    Olander RM; Muotiala A; Karvonen M; Kuronen T; Runeberg-Nyman K
    Microb Pathog; 1990 Jan; 8(1):37-45. PubMed ID: 2159104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni.
    Boulanger D; Reid GD; Sturrock RF; Wolowczuk I; Balloul JM; Grezel D; Pierce RJ; Otieno MF; Guerret S; Grimaud JA
    Parasite Immunol; 1991 Sep; 13(5):473-90. PubMed ID: 1956696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase.
    Ivanoff N; Phillips N; Schacht AM; Heydari C; Capron A; Riveau G
    Vaccine; 1996 Aug; 14(12):1123-31. PubMed ID: 8911008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
    Roberts M; Cropley I; Chatfield S; Dougan G
    Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.
    Leininger E; Bowen S; Renauld-Mongénie G; Rouse JH; Menozzi FD; Locht C; Heron I; Brennan MJ
    J Infect Dis; 1997 Jun; 175(6):1423-31. PubMed ID: 9180182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
    Berstad AKH; Holst J; Frøholm LO; Haugen IL; Wedege E; Oftung F; Haneberg B
    J Med Microbiol; 2000 Feb; 49(2):157-163. PubMed ID: 10670566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
    Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin.
    Menozzi FD; Gantiez C; Locht C
    FEMS Microbiol Lett; 1991 Feb; 78(1):59-64. PubMed ID: 2032624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines.
    Asgarian-Omran H; Golara M; Abdolmaleki S; Navabi SS; Alipour H; Khoshnoodi J; Hemmati A; Zarei S; Jeddi-Tehrani M; Shokri F
    Infect Dis (Lond); 2016 Feb; 48(2):127-32. PubMed ID: 26439274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of a Schistosoma mansoni 28-kilodalton glutathione S-transferase in the livers of transgenic mice and its effect on parasite infection.
    Xu X; Lemaire C; Grzych JM; Pierce RJ; Raccurt M; Mullier F; Zerimech F; Decavel JP; Peyrol S; Liu J; Fontaine J; Lafitte S; Capron A; Cesbron JY
    Infect Immun; 1997 Sep; 65(9):3867-74. PubMed ID: 9284165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.